April 27, 2024 01:55 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
6.1 magnitude earthquake hits Taiwan, no immediate damages reported | Arjuna awardee CRPF officer found guilty of sexual harassment charges, faces dismissal | Opposition's dreams shattered: PM Modi on Supreme Court's VVPAT verdict | Supreme Court rejects plea seeking 100 pct votes verification on EVMs, rules out returning to ballot papers | Voting concludes in 88 constituencies with 61% turnout by 5 pm
Israeli researchers develop method to rejuvenate kidneys

Israeli researchers develop method to rejuvenate kidneys

India Blooms News Service | @indiablooms | 22 Jan 2020, 12:03 pm

Jerusalem/Xinhua/UNI: Israeli researchers have discovered a method to rejuvenate the kidneys, which has the potential to eliminate the need for dialysis in the future, Israel's Sheba Medical Center said Wednesday.

In a study published in the journal Cell Reports, researchers from the center showed that it is possible to rejuvenate the kidneys and improve their function using the patient's own stem cells.

Previously, it was found that the adult kidney can constantly renew itself over time through the activity of colonies of cells that function to replace lost and degenerated cells in the kidney.

In the current study, the team developed a new technology that allows the extraction of such healthy kidney cells from diseased kidneys.
These cells are expanded into large numbers within a laboratory environment, and by generation of three-dimensional cultures called "kidney spheres", they show improved function to generate new kidney tissue and replace lost cells.

The cells are administered into the kidney, allowing them to rebuild it, positively influence neighboring cells and improve the kidney's function.

Because the newly developed technology relies on the patient's own cells, it circumvents problems associated with immune rejection.

This treatment, successfully tested on mice, resulted in improved renal function in the treated mice.

The results are expected to be further studied in clinical trials in patients with renal failure.  

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.